Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

DRAM vs IREN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

IREN Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 7–3 Matrix Metrics)

IREN Overall Winner 6-Pillar Tally: DRAM 2 – 3 IREN (1 Tie) Matrix Metrics: DRAM 3 – 7 IREN

As of Nov 16, 2026, IREN Limited (IREN) is the stronger overall head-to-head candidate over DRAM (DRAM) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). DRAM carries a Unified Composite Score of 49.1/100 (HOLD) at $39.27 (N/M Forward P/E, N/A operating margin), whereas IREN carries 48.2/100 (HOLD) at $16.39 (65.4x Forward P/E, -72.9% operating margin).

  • Composite vs. Pillar Nuance: While DRAM currently prints a higher short-term Unified Composite Score (49.1/100 HOLD vs. IREN 48.2/100 HOLD), IREN captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (-72.9% vs. N/A operating margin) and revenue trajectory (-5.0% vs. N/A YoY).
  • Technical & Structure Timing Caution: DRAM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.7); meanwhile IREN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 30.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About DRAM vs IREN
DRAM US Equity
DRAM
Institutional Equity
$39.27
-7.38% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 4.02β · 102% Vol
Unified Composite Score
49.1 / 100 HOLD
Tech 50.0 Fund 56.0 Flow 58.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -7.3%), weak momentum, RSI 38
RSI-14: 37.7 · SMA20: $45.52 · SMA50: $52.90
IREN NASDAQ Head-to-Head Winner
IREN Limited Ordinary Shares
Finance Services
$16.39
-9.8% 1D
Market Cap $7.7B
TTM Revenue $695M
Forward P/E 65.4x
Beta / 30D Vol 3.86β · 139% Vol
Unified Composite Score
48.2 / 100 HOLD
Tech 33.0 Fund 48.0 Flow 58.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -17.8%), weak momentum, RSI 30
RSI-14: 30.3 · SMA20: $23.03 · SMA50: $33.48

6-Pillar Scorecard Institutional Category Breakdown (DRAM 2 – 3 IREN)

Columns: Metric · DRAM · IREN
1. Valuation Multiples IREN
Forward P/E N/M 65.4x
Trailing P/E N/M 65.4x
PEG Ratio N/M 4.05x
EV / Revenue N/M 20.7x
2. Growth & Scale IREN
Revenue Growth (YoY) N/A -5.0%
Earnings Growth (YoY) N/A +42.9%
TTM Revenue (USD) N/A $695M
Market Cap N/A $7.7B
3. Profitability & Quality IREN
Gross Margin N/A 73.4%
Operating Margin N/A -72.9%
Net Profit Margin N/A -194.3%
Return on Equity (ROE) N/A -33.8%
4. Balance Sheet & Cash Flow DRAM
Cash Generation (TTM) N/A -$6.57B
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE $6.69B Net Debt (2.00x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning DRAM
Options Structure Phase BREAKDOWN BREAKDOWN
Current IV / %ile 86.4% (74th %ile) 129.7% (32nd %ile)
Put/Call OI Skew 0.83x (Call-Skewed) 2.67x (Put-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Markdown DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Capital Markets Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: DRAM (3) vs IREN (7)
Institutional Metric DRAM IREN Criterion Row Edge
Market Capitalization
Scale
N/A $7.7B Larger Scale IREN
Trailing P/E Ratio
Valuation
N/M 65.4x Lower Multiple IREN
Forward P/E Ratio
Valuation
N/M 65.4x Lower Multiple IREN
Revenue Growth (YoY)
Growth
N/A -5.0% Higher Growth IREN
Operating Margin (TTM)
Profitability
N/A -72.9% Higher Margin IREN
Net Profit Margin
Profitability
N/A -194.3% Higher Margin IREN
Return on Equity (ROE)
Capital Efficiency
N/A -33.8% Higher ROE IREN
52-Week Range Position
Momentum
24% ($26–$81) 1% ($16–$71) Stronger Trend DRAM
Beta / 30D Volatility
Risk Regime
4.02β · 102% Vol 3.86β · 139% Vol Lower Realized Risk DRAM
Unified Institutional Score
Composite Signal
49.1 / 100 (HOLD) 48.2 / 100 (HOLD) Higher Composite DRAM
Trailing 12M Revenue (USD)
Operating Scale
N/A $695M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 73.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 4.05x PEG · 20.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) -$6.57B ($6.69B Net Debt (2.00x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon DRAM +23.81 pp
DRAM: -15.46% · IREN: -39.27%
3M Horizon DRAM +32.25 pp
DRAM: -28.73% · IREN: -60.98%
6M Horizon DRAM +47.14 pp
DRAM: -20.38% · IREN: -67.52%
1Y Horizon DRAM +94.32 pp
DRAM: +41.46% · IREN: -52.86%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DRAM vs IREN. Trailing 12-month operating profitability (DRAM N/A vs IREN -72.9%) and valuation multiples (DRAM N/M vs IREN 65.4x Forward P/E) are benchmarked directly in Pillar 4 below.

DRAM ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
IREN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$695M
Gross Margin73.4%
Op. Margin-72.9%
ROE / Fwd P/E-33.8% · 65.4x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
DRAM BREAKDOWN
103d in phase · OBV DISTRIBUTION
Current IV 86.4%
IV Percentile 74th %ile
Put/Call OI Skew 0.83x (Call-Skewed)
IV Regime Elevated (60th–80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact DRAM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
IREN BREAKDOWN
120d in phase · OBV DISTRIBUTION
Current IV 129.7%
IV Percentile 32nd %ile
Put/Call OI Skew 2.67x (Put-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact IREN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
DRAM Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
IREN Moat Profile Cyclical / Execution-Driven Positioning
Capital Markets Operator
Competes within the Capital Markets value chain with $7.7B market capitalization and -72.9% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ DRAM vs IREN Key Questions & Quantitative Answers

As of Nov 16, 2026, IREN Limited (IREN) is the stronger overall head-to-head candidate over DRAM (DRAM) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). DRAM carries a Unified Composite Score of 49.1/100 (HOLD) at $39.27 (N/M Forward P/E, N/A operating margin), whereas IREN carries 48.2/100 (HOLD) at $16.39 (65.4x Forward P/E, -72.9% operating margin). Composite vs. Pillar Nuance: While DRAM currently prints a higher short-term Unified Composite Score (49.1/100 HOLD vs. IREN 48.2/100 HOLD), IREN captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (-72.9% vs. N/A operating margin) and revenue trajectory (-5.0% vs. N/A YoY). Technical & Structure Timing Caution: DRAM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.7); meanwhile IREN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 30.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

IREN leads the Growth & Scale pillar: DRAM posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with IREN at -5.0% YoY revenue growth and +42.9% YoY earnings growth on $695M TTM revenue (73.4% gross margin, -72.9% operating margin). On trailing 12-month operating scale, DRAM generates N/A in USD-normalized revenue versus $695M for IREN. In operating R&D and SG&A reinvestment, DRAM deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for IREN.

IREN screens cheaper on headline valuation multiples. DRAM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas IREN trades at 65.4x Forward P/E, 65.4x Trailing P/E, 4.05x PEG, and 20.7x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DRAM (N/A ROE) versus IREN (-33.8% ROE) capital efficiency.

In options market volatility and institutional positioning, DRAM carries 86.4% implied volatility (74th %ile, Elevated (60th–80th %ile)), a 0.83x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (4.02β · 102% Vol realized risk). By comparison, IREN carries 129.7% implied volatility (32nd %ile, Balanced (25th–60th %ile)), a 2.67x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (3.86β · 139% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.